| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States.
Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States.
Ivasiy R, Madden LM, Johnson KA, Machavariani E, Ahmad B, Oliveros D, Tan J, Kil N, Altice FL.
Int J Drug Policy. 2025 Apr;138:104748. doi: 10.1016/j.drugpo.2025.104748. Epub 2025 Feb 27. PMID: 40020306.
Abstract
https://www.sciencedirect.com/science/article/abs/pii/S0955395925000477